drugset / Trial / NCT00367445

A Clinical Trial Comparing Short-Term Efficacy and Safety of Exubera and Lantus

NCT00367445

Phase 4 Completed 30 enrolled Pfizer
RandomizedCrossoverOpen-labelTreatment

Summary

To compare short-term efficacy and safety of Exubera vs Lantus in patients with type 2 diabetes mellitus

Timeline

Start
2006-09
Primary completion
Completion
2007-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Protein / enzyme biologic Inhaled
Subject insulin glargine Protein / enzyme biologic